Ontario's Ministry of International Trade, is organizing a Trade Mission to the RESI Conference, September 6, 2018, Boston Marriott Copley Place Hotel. This Trade Mission will be able to accommodate a maximum of ten Ontario companies.

Proteocyte AI announced they have signed a partnership agreement to integrate Proscia’s technology with Straticyte™, a specific test for predicting the risk of progression to oral cancer.

Swift Medical, the world leader in enterprise-grade digital wound care management, has secured $11.6 million in funding

Applications for the 2018 ONtrepreneurs Competition are now open. The Ontario Neurotech Entrepreneurs (ONtrepreneurs) Program catalyzes early stage entrepreneurs to commercialize brain-related technologies by accessing funding and support to launch or grow their neurotechnology ventures.

A panel of investor-judges has selected Ontario-based oncology researcher Soror Sharifpoor of Polumiros Inc. as the winner of the 2018 FACIT Falcons' Fortunes competition. The $50,000 award is intended to support further development of their innovative cancer research.

Adrenalease announced the launch of a Kickstarter campaign to back their wearable posture apparel line. Once the campaign ends, the clothing is set to produce and ship to all backers by August 2018.

VBI Vaccines announced the completion of enrollment with the last patient receiving the first dose in the ongoing PROTECT Phase 3 study of Sci-B-Vac®, the company’s third-generation hepatitis B vaccine.

CellAegis Devices announced enrollment of the first patients in a U.S. clinical trial of its autoRIC® device.

The Impact Centre released a report on the Physical Technologies Forum, which summarized the ten big challenges Canada’s companies face when commercializing innovative physical technologies.

Today, Ontario announced it will invest up to $50 million in venture capital funds focused on life sciences.

The Ontario Capital Growth Corporation (OCGC) has issued an expression of interest to identify fund managers to partner with other institutional investors such as corporations, banks and pension funds.

Avocare has launched their newest product, Avocare Remote Care. Remote Care will empower patients by enabling them to securely message their own healthcare provider using secure web and mobile apps.